Logo image of INVZ

INNOVIZ TECHNOLOGIES LTD (INVZ) Stock Fundamental Analysis

NASDAQ:INVZ - Nasdaq - IL0011745804 - Common Stock - Currency: USD

1.035  -0.15 (-12.29%)

Fundamental Rating

4

Taking everything into account, INVZ scores 4 out of 10 in our fundamental rating. INVZ was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. INVZ has a great financial health rating, but its profitability evaluates not so good. INVZ shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year INVZ has reported negative net income.
INVZ had a negative operating cash flow in the past year.
In the past 5 years INVZ always reported negative net income.
INVZ had a negative operating cash flow in each of the past 5 years.
INVZ Yearly Net Income VS EBIT VS OCF VS FCFINVZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

The Return On Assets of INVZ (-73.85%) is worse than 90.00% of its industry peers.
The Return On Equity of INVZ (-115.10%) is worse than 86.67% of its industry peers.
Industry RankSector Rank
ROA -73.85%
ROE -115.1%
ROIC N/A
ROA(3y)-50.97%
ROA(5y)-63.9%
ROE(3y)-66%
ROE(5y)-85.82%
ROIC(3y)N/A
ROIC(5y)N/A
INVZ Yearly ROA, ROE, ROICINVZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

INVZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INVZ Yearly Profit, Operating, Gross MarginsINVZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -20K -40K -60K -80K

More info and screens

7

2. Health

2.1 Basic Checks

INVZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
INVZ has more shares outstanding than it did 1 year ago.
There is no outstanding debt for INVZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INVZ Yearly Shares OutstandingINVZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
INVZ Yearly Total Debt VS Total AssetsINVZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

INVZ has an Altman-Z score of -6.41. This is a bad value and indicates that INVZ is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of INVZ (-6.41) is worse than 90.00% of its industry peers.
There is no outstanding debt for INVZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.41
ROIC/WACCN/A
WACC9.11%
INVZ Yearly LT Debt VS Equity VS FCFINVZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

INVZ has a Current Ratio of 3.64. This indicates that INVZ is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.64, INVZ is in the better half of the industry, outperforming 68.33% of the companies in the same industry.
INVZ has a Quick Ratio of 3.59. This indicates that INVZ is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.59, INVZ belongs to the best of the industry, outperforming 80.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.59
INVZ Yearly Current Assets VS Current LiabilitesINVZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

7

3. Growth

3.1 Past

INVZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.43%, which is quite impressive.
INVZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 339.59%.
Measured over the past years, INVZ shows a very strong growth in Revenue. The Revenue has been growing by 222.33% on average per year.
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)339.59%
Revenue growth 3YN/A
Revenue growth 5Y222.33%
Sales Q2Q%29.77%

3.2 Future

INVZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.85% yearly.
The Revenue is expected to grow by 131.58% on average over the next years. This is a very strong growth
EPS Next Y33.28%
EPS Next 2Y17.61%
EPS Next 3Y15.28%
EPS Next 5Y30.85%
Revenue Next Year40.93%
Revenue Next 2Y120.32%
Revenue Next 3Y124.18%
Revenue Next 5Y131.58%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
INVZ Yearly Revenue VS EstimatesINVZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 500M 1B 1.5B 2B
INVZ Yearly EPS VS EstimatesINVZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INVZ. In the last year negative earnings were reported.
Also next year INVZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INVZ Price Earnings VS Forward Price EarningsINVZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INVZ Per share dataINVZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as INVZ's earnings are expected to grow with 15.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.61%
EPS Next 3Y15.28%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INVZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVIZ TECHNOLOGIES LTD

NASDAQ:INVZ (2/11/2025, 11:06:05 AM)

1.035

-0.15 (-12.29%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)02-26 2025-02-26/amc
Inst Owners33.46%
Inst Owner Change-48.41%
Ins Owners2.06%
Ins Owner ChangeN/A
Market Cap174.58M
Analysts78.18
Price Target2.79 (169.57%)
Short Float %6.72%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.79%
Min EPS beat(2)-6.56%
Max EPS beat(2)16.15%
EPS beat(4)2
Avg EPS beat(4)-1.8%
Min EPS beat(4)-20.87%
Max EPS beat(4)16.15%
EPS beat(8)3
Avg EPS beat(8)-1.28%
EPS beat(12)5
Avg EPS beat(12)-1.51%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)20.7%
Min Revenue beat(2)-0.64%
Max Revenue beat(2)42.03%
Revenue beat(4)3
Avg Revenue beat(4)23.88%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)42.03%
Revenue beat(8)5
Avg Revenue beat(8)9.68%
Revenue beat(12)5
Avg Revenue beat(12)-4.75%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)35.87%
PT rev (3m)18.49%
EPS NQ rev (1m)-2.64%
EPS NQ rev (3m)18.07%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.36%
Revenue NQ rev (1m)-2.34%
Revenue NQ rev (3m)-56.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.27
P/FCF N/A
P/OCF N/A
P/B 1.88
P/tB 1.88
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.2
BVpS0.55
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -73.85%
ROE -115.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.97%
ROA(5y)-63.9%
ROE(3y)-66%
ROE(5y)-85.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.51%
Cap/Sales 11.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.64
Quick Ratio 3.59
Altman-Z -6.41
F-Score5
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)156.39%
Cap/Depr(5y)202.39%
Cap/Sales(3y)158.31%
Cap/Sales(5y)179.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y33.28%
EPS Next 2Y17.61%
EPS Next 3Y15.28%
EPS Next 5Y30.85%
Revenue 1Y (TTM)339.59%
Revenue growth 3YN/A
Revenue growth 5Y222.33%
Sales Q2Q%29.77%
Revenue Next Year40.93%
Revenue Next 2Y120.32%
Revenue Next 3Y124.18%
Revenue Next 5Y131.58%
EBIT growth 1Y16.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.27%
EBIT Next 3Y9.52%
EBIT Next 5Y12.03%
FCF growth 1Y25.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.86%
OCF growth 3YN/A
OCF growth 5YN/A